Levosimendan en disfunción ventricular en el posoperatorio de cirugía cardíaca. Hospital Santa Clara de Bogotá D.C. Octubre 2011 a Septiembre 2012

Autores:: Badillo, Expedito
Hennessey, José María
Santis, Edward Alonso

Tipo de recurso:: Article of journal

Fecha de publicación:: 2015

Institución:: Fundación Universitaria de Ciencias de la Salud - FUCS

Repositorio:: Repositorio Digital Institucional ReDi

Idioma:: spa

id	FUCS2_e463f59e2cd8732799aed1f4df48c5a4
oai_identifier_str	oai:repositorio.fucsalud.edu.co:001/2491
network_acronym_str	FUCS2
network_name_str	Repositorio Digital Institucional ReDi
repository_id_str
dc.title.spa.fl_str_mv	Levosimendan en disfunción ventricular en el posoperatorio de cirugía cardíaca. Hospital Santa Clara de Bogotá D.C. Octubre 2011 a Septiembre 2012
dc.title.translated.eng.fl_str_mv	Levosimendan in ventricular dysfunction in the postoperative period of cardiac surgery. Hospital Santa Clara de Bogotá D.C. October 2011 to September 2012
title	Levosimendan en disfunción ventricular en el posoperatorio de cirugía cardíaca. Hospital Santa Clara de Bogotá D.C. Octubre 2011 a Septiembre 2012
spellingShingle	Levosimendan en disfunción ventricular en el posoperatorio de cirugía cardíaca. Hospital Santa Clara de Bogotá D.C. Octubre 2011 a Septiembre 2012 levosimendan disfunción ventricular fracción de eyección levosimendan ventricular dysfunction ejection fraction
title_short	Levosimendan en disfunción ventricular en el posoperatorio de cirugía cardíaca. Hospital Santa Clara de Bogotá D.C. Octubre 2011 a Septiembre 2012
title_full	Levosimendan en disfunción ventricular en el posoperatorio de cirugía cardíaca. Hospital Santa Clara de Bogotá D.C. Octubre 2011 a Septiembre 2012
title_fullStr	Levosimendan en disfunción ventricular en el posoperatorio de cirugía cardíaca. Hospital Santa Clara de Bogotá D.C. Octubre 2011 a Septiembre 2012
title_full_unstemmed	Levosimendan en disfunción ventricular en el posoperatorio de cirugía cardíaca. Hospital Santa Clara de Bogotá D.C. Octubre 2011 a Septiembre 2012
title_sort	Levosimendan en disfunción ventricular en el posoperatorio de cirugía cardíaca. Hospital Santa Clara de Bogotá D.C. Octubre 2011 a Septiembre 2012
dc.creator.fl_str_mv	Badillo, Expedito Hennessey, José María Santis, Edward Alonso
dc.contributor.author.spa.fl_str_mv	Badillo, Expedito Hennessey, José María Santis, Edward Alonso
dc.subject.spa.fl_str_mv	levosimendan disfunción ventricular fracción de eyección
topic	levosimendan disfunción ventricular fracción de eyección levosimendan ventricular dysfunction ejection fraction
dc.subject.eng.fl_str_mv	levosimendan ventricular dysfunction ejection fraction
publishDate	2015
dc.date.accessioned.none.fl_str_mv	2015-12-01 00:00:00 2022-02-21T20:38:01Z
dc.date.issued.none.fl_str_mv	2015-12-01
dc.date.available.none.fl_str_mv	2015-12-01 00:00:00 2022-02-21T20:38:01Z
dc.type.spa.fl_str_mv	Artículo de revista
dc.type.eng.fl_str_mv	Journal article
dc.type.coar.fl_str_mv	http://purl.org/coar/resource_type/c_2df8fbb1
dc.type.coar.spa.fl_str_mv	http://purl.org/coar/resource_type/c_6501
dc.type.driver.spa.fl_str_mv	info:eu-repo/semantics/article
dc.type.version.spa.fl_str_mv	info:eu-repo/semantics/publishedVersion
dc.type.content.spa.fl_str_mv	Text
dc.type.coarversion.spa.fl_str_mv	http://purl.org/coar/version/c_970fb48d4fbd8a85
format	http://purl.org/coar/resource_type/c_6501
status_str	publishedVersion
dc.identifier.doi.none.fl_str_mv	10.31260/RepertMedCir.v24.n4.2015.601
dc.identifier.issn.none.fl_str_mv	0121-7372
dc.identifier.uri.none.fl_str_mv	https://repositorio.fucsalud.edu.co/handle/001/2491
dc.identifier.eissn.none.fl_str_mv	2462-991X
dc.identifier.url.none.fl_str_mv	https://doi.org/10.31260/RepertMedCir.v24.n4.2015.601
identifier_str_mv	10.31260/RepertMedCir.v24.n4.2015.601 0121-7372 2462-991X
url	https://repositorio.fucsalud.edu.co/handle/001/2491 https://doi.org/10.31260/RepertMedCir.v24.n4.2015.601
dc.language.iso.spa.fl_str_mv	spa
language	spa
dc.relation.references.spa.fl_str_mv	Higgins TL, Estafanous FG, Loop FD, Beck GJ, Blum JM, Paranandi L. Stratification of morbidity and mortality outcome by preoperative risk factors in coronary artery bypass patients. A clinical severity score. JAMA. 1992;267(17):2344-8. Epub 1992/05/06. Eslava-Schmalbach JH, Rincón CJ, Guarnizo CC. “Inequidad” de la expectativa de vida al nacer por sexo y “departamentos” de Colombia. Biomédica; Vol 33, núm 3 (2013). doi: 10.7705/biomedica.v33i3.811. Delgado JF. [Levosimendan in acute heart failure: past, present and future]. Rev Esp Cardiol. 2006;59(4):309-12. Epub 2006/05/20. Levosimendan en la insuficiencia cardíaca aguda: pasado, presente y futuro. Breisblatt WM, Stein KL, Wolfe CJ, Follansbee WP, Capozzi J, Armitage JM, et al. Acute myocardial dysfunction and recovery: a common occurrence after coronary bypass surgery. J Am Coll Cardiol. 1990;15(6):1261-9. Epub 1990/05/01. Pollesello P, Mebazaa A. ATP-dependent potassium channels as a key target for the treatment of myocardial and vascular dysfunction. Curr Opin Crit Care. 2004;10(6):436-41. Epub 2004/12/24. Garlid KD, Dos Santos P, Xie ZJ, Costa AD, Paucek P. Mitochondrial potassium transport: the role of the mitochondrial ATP-sensitive K(+) channel in cardiac function and cardioprotection. Biochim Biophys Acta. 2003;1606(1-3):1-21. Epub 2003/09/26. Malliotakis P, Xenikakis T, Linardakis M, Hassoulas J. Haemodynamic effects of levosimendan for low cardiac output after cardiac surgery: a case series. Hellenic J Cardiol. 2007;48(2):80-8. Epub 2007/05/11. Nashef SAM. European system for cardiac operative risk evaluation (EuroSCORE). European Journal of Cardio - Thoracic Surgery. 1999;16(1):4. Mangano DT. Biventricular function after myocardial revascularization in humans: deterioration and recovery patterns during the first 24 hours. Anesthesiology. 1985;62(5):571-7. Epub 1985/05/01. Tamargo J, Lopez-Sendon J. [Rationale and clinical evidence for the effects of new pharmacological treatments for heart failure]. Rev Esp Cardiol. 2004;57(5):447-64. Epub 2004/05/21. Bases y evidencias clinicas de los efectos de los nuevos tratamientos farmacologicos en la insuficiencia cardíaca. Moiseyev VS, Poder P, Andrejevs N, Ruda MY, Golikov AP, Lazebnik LB, et al. Safety and efficacy of a novel calcium sensitizer, levosimendan, in patients with left ventricular failure due to an acute myocardial infarction. A randomized, placebo-controlled, double-blind study (RUSSLAN). Eur Heart J. 2002;23(18):1422-32. Epub 2002/09/05. Benlolo S, Lefoll C, Katchatouryan V, Payen D, Mebazaa A. Successful use of levosimendan in a patient with peripartum cardiomyopathy. Anesth Analg.2004;98(3):822-4, table of contents. Epub 2004/02/26. Cheung EH, Arcidi JM, Jr., Dorsey LM, Vinten-Johansen J, Hatcher CR, Jr., Guyton RA. Reperfusion of infarcting myocardium: benefit of surgical reperfusion in a chronic model. Ann Thorac Surg. 1989;48(3):331-8. Epub 1989/09/01. Vinten-Johansen J, Chiantella V, Johnston WE, Jolly BT, Kendricks WD, Hester TO, et al. Adjuvant N-(2-mercaptopropionyl)-glycine in blood cardioplegia does not improve myocardial protection in ischemically damaged hearts. J Thorac Cardiovasc Surg. 1990;100(1):65-76. Epub 1990/07/01. Yokoyama H, Julian JS, Vinten-Johansen J, Johnston WE, Smith TD, McGee DS, et al. Postischemic [Ca2+] repletion improves cardiac performance without altering oxygen demands. Ann Thorac Surg. 1990;49(6):894-902. Epub 1990/06/01. Cunningham JN, Jr., Adams PX, Knopp EA, Baumann FG, Snively SL, Gross RI, et al. Preservation of ATP, ultrastructure, and ventricular function after aortic cross-clamping and reperfusion. Clinical use of blood potassium cardioplegia. J Thorac Cardiovasc Surg. 1979;78(5):708-20. Epub 1979/11/01. Opie LH. The heart: physiology, from cell to circulation: Lippincott-Raven; 1998 1998. 637 p. Kevin LG, Novalija E, Stowe DF. Reactive oxygen species as mediators of cardiac injury and protection: the relevance to anesthesia practice. Anesth Analg.2005;101(5):1275-87. Epub 2005/10/26. Kloner RA, Jennings RB. Consequences of brief ischemia: stunning, preconditioning, and their clinical implications: part 2. Circulation. 2001;104(25):3158-67. Epub 2001/12/19. Follath F, Cleland JG, Just H, Papp JG, Scholz H, Peuhkurinen K, et al. Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): a randomised double-blind trial. Lancet. 2002;360(9328):196-202. Epub 2002/07/23. Luu M, Stevenson LW, Brunken RC, Drinkwater DM, Schelbert HR, Tillisch JH. Delayed recovery of revascularized myocardium after referral for cardiac transplantation. Am Heart J. 1990;119(3 Pt 1):668-70. Epub 1990/03/01. Greenberg B, Borghi C, Perrone S. Pharmacotherapeutic approaches for decompensated heart failure: a role for the calcium sensitiser, levosimendan? Eur J Heart Fail. 2003;5(1):13-21. Epub 2003/02/01. Alvarez J, Bouzada M, Fernandez AL, Caruezo V, Taboada M, Rodriguez J, et al. [Hemodynamic effects of levosimendan compared with dobutamine in patients with low cardiac output after cardiac surgery]. Rev Esp Cardiol. 2006;59(4):338-45. Epub 2006/05/20. Comparacion de los efectos hemodinamicos del levosimendan con la dobutamina en pacientes con bajo gasto despues de cirugia cardíaca. Levin RL, Degrange MA, Porcile R, Salvagio F, Blanco N, Botbol AL, et al. [The calcium sensitizer levosimendan gives superior results to dobutamine in postoperative low cardiac output syndrome]. Rev Esp Cardiol. 2008;61(5):471-9. Epub 2008/05/09. Superioridad del sensibilizante al calcio levosimendan comparado con dobutamina en el sindrome de bajo gasto cardíaco postoperatorio. Garcia Gonzalez MJ, Dominguez Rodriguez A. Pharmacologic treatment of heart failure due to ventricular dysfunction by myocardial stunning: potential role of levosimendan. Am J Cardiovasc Drugs. 2006;6(2):69-75. Epub 2006/03/25. Raja SG, Rayen BS. Levosimendan in cardiac surgery: current best available evidence. Ann Thorac Surg. 2006;81(4):1536-46. Epub 2006/03/28. Lilleberg J, Nieminen MS, Akkila J, Heikkila L, Kuitunen A, Lehtonen L, et al. Effects of a new calcium sensitizer, levosimendan, on haemodynamics, coronary blood flow and myocardial substrate utilization early after coronary artery bypass grafting. Eur Heart J. 1998;19(4):660-8. Epub 1998/05/23.
dc.relation.bitstream.none.fl_str_mv	https://revistas.fucsalud.edu.co/index.php/repertorio/article/download/601/639
dc.relation.citationedition.spa.fl_str_mv	Núm. 4 , Año 2015 : Octubre – Diciembre
dc.relation.citationendpage.none.fl_str_mv	283
dc.relation.citationissue.spa.fl_str_mv	4
dc.relation.citationstartpage.none.fl_str_mv	275
dc.relation.citationvolume.spa.fl_str_mv	24
dc.relation.ispartofjournal.spa.fl_str_mv	Revista Repertorio de Medicina y Cirugía
dc.rights.spa.fl_str_mv	Fundación Universitaria de Ciencias de la Salud FUCS - 0
dc.rights.accessrights.spa.fl_str_mv	info:eu-repo/semantics/openAccess
dc.rights.uri.spa.fl_str_mv	https://creativecommons.org/licenses/by-nc-sa/4.0/
dc.rights.coar.spa.fl_str_mv	http://purl.org/coar/access_right/c_abf2
rights_invalid_str_mv	Fundación Universitaria de Ciencias de la Salud FUCS - 0 https://creativecommons.org/licenses/by-nc-sa/4.0/ http://purl.org/coar/access_right/c_abf2
eu_rights_str_mv	openAccess
dc.format.mimetype.spa.fl_str_mv	application/pdf
dc.publisher.spa.fl_str_mv	Sociedad de Cirugía de Bogotá, Hospital de San José y Fundación Universitaria de Ciencias de la Salud
dc.source.spa.fl_str_mv	https://revistas.fucsalud.edu.co/index.php/repertorio/article/view/601
institution	Fundación Universitaria de Ciencias de la Salud - FUCS
bitstream.url.fl_str_mv	https://repositorio.fucsalud.edu.co/bitstreams/90f94f6b-60e6-47cc-a99a-3d6b75dcce55/download
bitstream.checksum.fl_str_mv	17698c33a88973390d35deb92485ca28
bitstream.checksumAlgorithm.fl_str_mv	MD5
repository.name.fl_str_mv	Repositorio Digital de la Fundación Universitaria de Ciencias de la Salud
repository.mail.fl_str_mv	redi@fucsalud.edu.co
_version_	1814355535413116928
spelling	Badillo, Expeditofb608ac0241cdcae77b1fbe51dec5332300Hennessey, José María922155eaf919e8da1ce9ec0319581910500Santis, Edward Alonso7ae6287ce21d92db9ec584abc18f59f93002015-12-01 00:00:002022-02-21T20:38:01Z2015-12-012015-12-01 00:00:002022-02-21T20:38:01ZSociedad de Cirugía de Bogotá, Hospital de San José y Fundación Universitaria de Ciencias de la SaludFundación Universitaria de Ciencias de la Salud FUCS - 0info:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by-nc-sa/4.0/http://purl.org/coar/access_right/c_abf2https://revistas.fucsalud.edu.co/index.php/repertorio/article/view/601levosimendandisfunción ventricularfracción de eyecciónlevosimendanventricular dysfunctionejection fractionLevosimendan en disfunción ventricular en el posoperatorio de cirugía cardíaca. Hospital Santa Clara de Bogotá D.C. Octubre 2011 a Septiembre 2012Levosimendan in ventricular dysfunction in the postoperative period of cardiac surgery. Hospital Santa Clara de Bogotá D.C. October 2011 to September 2012application/pdfArtículo de revistaJournal articlehttp://purl.org/coar/resource_type/c_6501http://purl.org/coar/resource_type/c_2df8fbb1info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionTexthttp://purl.org/coar/version/c_970fb48d4fbd8a8510.31260/RepertMedCir.v24.n4.2015.6010121-7372https://repositorio.fucsalud.edu.co/handle/001/24912462-991Xhttps://doi.org/10.31260/RepertMedCir.v24.n4.2015.601spaHiggins TL, Estafanous FG, Loop FD, Beck GJ, Blum JM, Paranandi L. Stratification of morbidity and mortality outcome by preoperative risk factors in coronary artery bypass patients. A clinical severity score. JAMA. 1992;267(17):2344-8. Epub 1992/05/06.Eslava-Schmalbach JH, Rincón CJ, Guarnizo CC. “Inequidad” de la expectativa de vida al nacer por sexo y “departamentos” de Colombia. Biomédica; Vol 33, núm 3 (2013). doi: 10.7705/biomedica.v33i3.811.Delgado JF. [Levosimendan in acute heart failure: past, present and future]. Rev Esp Cardiol. 2006;59(4):309-12. Epub 2006/05/20. Levosimendan en la insuficiencia cardíaca aguda: pasado, presente y futuro.Breisblatt WM, Stein KL, Wolfe CJ, Follansbee WP, Capozzi J, Armitage JM, et al. Acute myocardial dysfunction and recovery: a common occurrence after coronary bypass surgery. J Am Coll Cardiol. 1990;15(6):1261-9. Epub 1990/05/01.Pollesello P, Mebazaa A. ATP-dependent potassium channels as a key target for the treatment of myocardial and vascular dysfunction. Curr Opin Crit Care. 2004;10(6):436-41. Epub 2004/12/24.Garlid KD, Dos Santos P, Xie ZJ, Costa AD, Paucek P. Mitochondrial potassium transport: the role of the mitochondrial ATP-sensitive K(+) channel in cardiac function and cardioprotection. Biochim Biophys Acta. 2003;1606(1-3):1-21. Epub 2003/09/26.Malliotakis P, Xenikakis T, Linardakis M, Hassoulas J. Haemodynamic effects of levosimendan for low cardiac output after cardiac surgery: a case series. Hellenic J Cardiol. 2007;48(2):80-8. Epub 2007/05/11.Nashef SAM. European system for cardiac operative risk evaluation (EuroSCORE). European Journal of Cardio - Thoracic Surgery. 1999;16(1):4.Mangano DT. Biventricular function after myocardial revascularization in humans: deterioration and recovery patterns during the first 24 hours. Anesthesiology. 1985;62(5):571-7. Epub 1985/05/01.Tamargo J, Lopez-Sendon J. [Rationale and clinical evidence for the effects of new pharmacological treatments for heart failure]. Rev Esp Cardiol. 2004;57(5):447-64. Epub 2004/05/21. Bases y evidencias clinicas de los efectos de los nuevos tratamientos farmacologicos en la insuficiencia cardíaca.Moiseyev VS, Poder P, Andrejevs N, Ruda MY, Golikov AP, Lazebnik LB, et al. Safety and efficacy of a novel calcium sensitizer, levosimendan, in patients with left ventricular failure due to an acute myocardial infarction. A randomized, placebo-controlled, double-blind study (RUSSLAN). Eur Heart J. 2002;23(18):1422-32. Epub 2002/09/05.Benlolo S, Lefoll C, Katchatouryan V, Payen D, Mebazaa A. Successful use of levosimendan in a patient with peripartum cardiomyopathy. Anesth Analg.2004;98(3):822-4, table of contents. Epub 2004/02/26.Cheung EH, Arcidi JM, Jr., Dorsey LM, Vinten-Johansen J, Hatcher CR, Jr., Guyton RA. Reperfusion of infarcting myocardium: benefit of surgical reperfusion in a chronic model. Ann Thorac Surg. 1989;48(3):331-8. Epub 1989/09/01.Vinten-Johansen J, Chiantella V, Johnston WE, Jolly BT, Kendricks WD, Hester TO, et al. Adjuvant N-(2-mercaptopropionyl)-glycine in blood cardioplegia does not improve myocardial protection in ischemically damaged hearts. J Thorac Cardiovasc Surg. 1990;100(1):65-76. Epub 1990/07/01.Yokoyama H, Julian JS, Vinten-Johansen J, Johnston WE, Smith TD, McGee DS, et al. Postischemic [Ca2+] repletion improves cardiac performance without altering oxygen demands. Ann Thorac Surg. 1990;49(6):894-902. Epub 1990/06/01.Cunningham JN, Jr., Adams PX, Knopp EA, Baumann FG, Snively SL, Gross RI, et al. Preservation of ATP, ultrastructure, and ventricular function after aortic cross-clamping and reperfusion. Clinical use of blood potassium cardioplegia. J Thorac Cardiovasc Surg. 1979;78(5):708-20. Epub 1979/11/01.Opie LH. The heart: physiology, from cell to circulation: Lippincott-Raven; 1998 1998. 637 p.Kevin LG, Novalija E, Stowe DF. Reactive oxygen species as mediators of cardiac injury and protection: the relevance to anesthesia practice. Anesth Analg.2005;101(5):1275-87. Epub 2005/10/26.Kloner RA, Jennings RB. Consequences of brief ischemia: stunning, preconditioning, and their clinical implications: part 2. Circulation. 2001;104(25):3158-67. Epub 2001/12/19.Follath F, Cleland JG, Just H, Papp JG, Scholz H, Peuhkurinen K, et al. Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): a randomised double-blind trial. Lancet. 2002;360(9328):196-202. Epub 2002/07/23.Luu M, Stevenson LW, Brunken RC, Drinkwater DM, Schelbert HR, Tillisch JH. Delayed recovery of revascularized myocardium after referral for cardiac transplantation. Am Heart J. 1990;119(3 Pt 1):668-70. Epub 1990/03/01.Greenberg B, Borghi C, Perrone S. Pharmacotherapeutic approaches for decompensated heart failure: a role for the calcium sensitiser, levosimendan? Eur J Heart Fail. 2003;5(1):13-21. Epub 2003/02/01.Alvarez J, Bouzada M, Fernandez AL, Caruezo V, Taboada M, Rodriguez J, et al. [Hemodynamic effects of levosimendan compared with dobutamine in patients with low cardiac output after cardiac surgery]. Rev Esp Cardiol. 2006;59(4):338-45. Epub 2006/05/20. Comparacion de los efectos hemodinamicos del levosimendan con la dobutamina en pacientes con bajo gasto despues de cirugia cardíaca.Levin RL, Degrange MA, Porcile R, Salvagio F, Blanco N, Botbol AL, et al. [The calcium sensitizer levosimendan gives superior results to dobutamine in postoperative low cardiac output syndrome]. Rev Esp Cardiol. 2008;61(5):471-9. Epub 2008/05/09. Superioridad del sensibilizante al calcio levosimendan comparado con dobutamina en el sindrome de bajo gasto cardíaco postoperatorio.Garcia Gonzalez MJ, Dominguez Rodriguez A. Pharmacologic treatment of heart failure due to ventricular dysfunction by myocardial stunning: potential role of levosimendan. Am J Cardiovasc Drugs. 2006;6(2):69-75. Epub 2006/03/25.Raja SG, Rayen BS. Levosimendan in cardiac surgery: current best available evidence. Ann Thorac Surg. 2006;81(4):1536-46. Epub 2006/03/28.Lilleberg J, Nieminen MS, Akkila J, Heikkila L, Kuitunen A, Lehtonen L, et al. Effects of a new calcium sensitizer, levosimendan, on haemodynamics, coronary blood flow and myocardial substrate utilization early after coronary artery bypass grafting. Eur Heart J. 1998;19(4):660-8. Epub 1998/05/23.https://revistas.fucsalud.edu.co/index.php/repertorio/article/download/601/639Núm. 4 , Año 2015 : Octubre – Diciembre283427524Revista Repertorio de Medicina y CirugíaPublicationOREORE.xmltext/xml2676https://repositorio.fucsalud.edu.co/bitstreams/90f94f6b-60e6-47cc-a99a-3d6b75dcce55/download17698c33a88973390d35deb92485ca28MD51001/2491oai:repositorio.fucsalud.edu.co:001/24912024-02-02 13:06:10.728https://creativecommons.org/licenses/by-nc-sa/4.0/Fundación Universitaria de Ciencias de la Salud FUCS - 0metadata.onlyhttps://repositorio.fucsalud.edu.coRepositorio Digital de la Fundación Universitaria de Ciencias de la Saludredi@fucsalud.edu.co

Levosimendan en disfunción ventricular en el posoperatorio de cirugía cardíaca. Hospital Santa Clara de Bogotá D.C. Octubre 2011 a Septiembre 2012

Publicaciones similares